The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
7-(cyclopropylmethoxy)-5-fluoro-2-((((1r,4r)-4-hydroxycyclohexyl)thio)methyl)quinazolin-4(3H)-one ID: ALA5179405
Cas Number: 2360851-29-0
PubChem CID: 138696916
Product Number: R414311, Order Now?
Max Phase: Preclinical
Molecular Formula: C19H23FN2O3S
Molecular Weight: 378.47
Associated Items:
Names and Identifiers Canonical SMILES: O=c1[nH]c(CS[C@H]2CC[C@H](O)CC2)nc2cc(OCC3CC3)cc(F)c12
Standard InChI: InChI=1S/C19H23FN2O3S/c20-15-7-13(25-9-11-1-2-11)8-16-18(15)19(24)22-17(21-16)10-26-14-5-3-12(23)4-6-14/h7-8,11-12,14,23H,1-6,9-10H2,(H,21,22,24)/t12-,14-
Standard InChI Key: NKZDEFKPZSLQRF-MQMHXKEQSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
-1.7292 1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0146 1.6498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3026 1.2379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3026 0.4126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0128 0.0008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7292 0.4089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4120 1.6506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1267 1.2378 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.1267 0.4126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4120 0.0000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.4120 2.4757 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.8414 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8414 -0.8252 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.5562 -1.2378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2709 -0.8252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9857 -1.2378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9857 -2.0632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2709 -2.4757 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5562 -2.0632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7004 -2.4757 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.0146 2.4752 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-2.4440 -0.0036 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.1588 0.4089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8734 -0.0036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7004 -0.0036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2870 -0.7179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
3 7 1 0
8 7 1 0
9 8 1 0
10 9 2 0
4 10 1 0
7 11 2 0
9 12 1 0
12 13 1 0
14 13 1 1
15 14 1 0
16 15 1 0
17 16 1 0
18 17 1 0
19 18 1 0
14 19 1 0
17 20 1 6
2 21 1 0
6 22 1 0
22 23 1 0
23 24 1 0
25 24 1 0
25 26 1 0
24 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 378.47Molecular Weight (Monoisotopic): 378.1413AlogP: 3.39#Rotatable Bonds: 6Polar Surface Area: 75.21Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.37CX Basic pKa: 3.31CX LogP: 2.36CX LogD: 2.35Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.81Np Likeness Score: -0.99
References 1. Nizi MG, Maksimainen MM, Murthy S, Massari S, Alaviuhkola J, Lippok BE, Sowa ST, Galera-Prat A, Prunskaite-Hyyryläinen R, Lüscher B, Korn P, Lehtiö L, Tabarrini O.. (2022) Potent 2,3-dihydrophthalazine-1,4-dione derivatives as dual inhibitors for mono-ADP-ribosyltransferases PARP10 and PARP15., 237 [PMID:35500474 ] [10.1016/j.ejmech.2022.114362 ] 2. Nizi MG, Maksimainen MM, Lehtiö L, Tabarrini O.. (2022) Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules., 65 (11.0): [PMID:35608571 ] [10.1021/acs.jmedchem.2c00281 ] 3. EUbOPEN. (2023) EUbOPEN Chemogenomics Library - IncuCyte, [10.6019/CHEMBL5303304 ] 4. EUbOPEN. (2023) Tm Shift (DSF) assay results for EUbOPEN Chemogenomics Library, [10.6019/CHEMBL5308504 ]